Newborns at risk of the potentially deadly necrotizing enterocolitis may soon be closer to a preventative strategy, thanks to new collaborative research from Boston and Beijing.
Building on earlier findings, scientists concluded that butyrate – a chemical compound produced from the breastmilk-probiotics combination – is indeed anti-inflammatory.
Please find details in this open-access article from the American Journal of Physiology-Gastrointestinal and Liver Physiology: ‘Short chain fatty acid butyrate, a breast milk metabolite, enhances immature intestinal barrier function genes in response to inflammation in vitro and in vivo’.
The study was funded in part by a grant to the Mucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children, Harvard Medical School, from FLRF.
Interested in keeping current on this and other news? Sign up for our newsletter.